ArticleFrontiers in immunology2023

Novel NKG2D-directed bispecific antibodies enhance antibody-mediated killing of malignant B cells by NK cells and T cells.

Sebastian Lutz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.